-
ONCSQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
ONCOSEC MEDICAL (ONCSQ)
Company Profile
Quarter (USD) | Jan 23 | Oct 22 | Jul 22 | Apr 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Jul 22 | Jul 21 | Jul 20 | Jul 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.68 mm | 3.68 mm | 3.68 mm | 3.68 mm | 3.68 mm | 3.68 mm |
Cash burn (monthly) | 682.12 k | 1.80 mm | 2.55 mm | 2.79 mm | 2.20 mm | 2.08 mm |
Cash used (since last report) | 17.10 mm | 45.01 mm | 64.02 mm | 70.02 mm | 55.23 mm | 52.20 mm |
Cash remaining | -13.41 mm | -41.32 mm | -60.34 mm | -66.34 mm | -51.55 mm | -48.52 mm |
Runway (months of cash) | -19.7 | -23.0 | -23.6 | -23.7 | -23.4 | -23.3 |
13F holders | Current |
---|---|
Total holders | 27 |
Opened positions | 2 |
Closed positions | 7 |
Increased positions | 4 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 35.20 mm |
Total shares | 16.91 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
China Grand Pharmaceutical & Healthcare | 10.00 mm | $18.60 mm |
Avidity Partners Management | 2.95 mm | $2.19 mm |
Alpha | 1.72 mm | $11.63 mm |
Vanguard | 731.52 k | $543.00 k |
BK The Bank of New York Mellon Corporation | 383.49 k | $285.00 k |
Salzhauer Michael | 296.28 k | $220.00 k |
Geode Capital Management | 272.25 k | $201.00 k |
Tocqueville Asset Management | 74.50 k | $55.00 k |
Renaissance Technologies | 72.90 k | $54.00 k |
Long Focus Capital Management | 69.23 k | $51.00 k |